Purchase Order 36C26219P0007
- Not listed
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $976,800.00 firm-fixed price purchase order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, for the emergency compounding of hazardous chemotherapy drugs. The order was awarded on November 27, 2018 with a performance period through January 31, 2019. Avella, a subsidiary of UnitedHealth Group Incorporated, provides specialized pharmacy services to support VA oncology and infusion...
- This federal contract award to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, is for medication compounding services provided to the Department of Veterans Affairs Veterans Health Administration (VA-VHA). The $424,949.34 firm fixed-price purchase order was awarded on March 4, 2018, with a completion date of May 31, 2018. Avella, a subsidiary of UnitedHealth Group, has received numerous VA-VHA awards for specialized pharmacy services involving chemotherapy and hazardous...
- This federal contract award to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, is for the provision of custom dosed chemotherapy intravenous (IV) medications to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $132,504.84 firm fixed price purchase order has a period of performance through June 30, 2024. Avella Specialty Pharmacy is a subsidiary of UnitedHealth Group Incorporated and operates as a 503A certified pharmacy, specializing...
- The Department of Veterans Affairs (VA) has awarded a Delivery Order contract to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The $40,000.00 Firm Fixed Price contract is for pharmacy compounding services to support VA oncology and infusion treatment programs nationwide. Avella, which is a 503A certified pharmacy, will leverage its expertise in aseptic techniques for hazardous drug preparation to deliver customized...
- This federal contract award to Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy) is for chemotherapy compounding services for the Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract has a ceiling value of $97,052.49 and a performance period running through November 16, 2024. Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated, specializes in compounding customized chemotherapy agents, hazardous sterile preparations,...
- The U.S. Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $216,982.32 firm fixed-price definitive contract for compounding services to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract, which has no set-aside designation, was awarded on December 26, 2019 with a completion date of December 25, 2020. As the prime contractor, Avella Specialty Pharmacy will provide specialized...
- The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a Blanket Purchase Agreement (BPA) call to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. This BPA call, valued at $500,000.00, is for the renewal of a contract to provide chemotherapy compounding services over a one-year period of performance ending on November 16, 2023. Avella will perform the work at its own facilities to support VA...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The $441,256.72 firm fixed-price delivery order is for the provision of hazardous pharmaceutical compounds to support VA oncology and infusion treatment programs in Las Vegas, Nevada. The contract has no set-aside designation and is not...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm-fixed-price purchase order contract to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The $1,875,405.34 contract is for the provision of compounded chemotherapy drugs to support VA oncology and infusion treatment programs at the VA Long Beach Healthcare System in California. The contract period of performance is April 2, 2019 to...
- This is a firm-fixed-price contract awarded by the Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, for the provision of compounded chemotherapy medications. The contract is valued at $340,949.82 and has an ultimate completion date of September 30, 2024. The original solicitation was for the VA Long Beach Healthcare System to acquire approximately 30 hazardous chemotherapy drugs and supportive medications to be delivered weekly over...
This contract was awarded by the Department of Veterans Affairs Veterans Health Administration (VA-VHA) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, to provide compounded chemotherapy agents. The $576,800.00 firm fixed price purchase order has a completion date of January 31, 2019. Avella, a subsidiary of UnitedHealth Group Incorporated, specializes in hazardous sterile compounding and has received numerous prior awards from the VA-VHA to supply customized cancer drugs and other pharmaceutical products to support the agency's oncology and infusion treatment programs for veterans. The contract has no set-aside designation. Avella performs the work at its own facilities while partnering with various VA Veterans Integrated Service Networks (VISNs) and VA medical centers across the country.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $576.8k | 10/1/18 |